www.anixa.com Open in urlscan Pro
35.157.161.45  Public Scan

Form analysis
0 forms found in the DOM

Text Content

Nasdaq: ANIX
 * Home
 * About
   * Overview
   * Management Team
   * Board of Directors
   * Scientific Advisors
 * Technologies
   * CAR-T
     * Introduction
     * Markets
     * Science
     * Collaborators
   * Cancer Vaccines
     * Introduction
     * Markets
     * Science
     * Collaborators
   * COVID-19
     * Introduction
     * Science
     * Collaborators
 * Pipeline
 * Investors
   * Overview
   * News Releases
   * Events & Presentations
     * Events
     * Corporate Presentation
   * Stock Information
     * Quote
     * Charts
     * Historical Data
     * Analyst Coverage
   * SEC Filings
     * SEC Filings
   * Financial Reports
     * Annual Reports
     * Quarterly Reports
   * Corporate Governance
     * Governance Documents
     * Committee Charters
 * News
   * Press Releases
   * Anixa In The News
   * Publications
 * Contact Us


ANIXA IS FOCUSED ON THE TREATMENT AND PREVENTION OF CANCER AND INFECTIOUS
DISEASES.

Anixa Biosciences, Inc. is developing therapies and vaccines that are focused on
critical unmet needs in oncology and infectious disease.  Anixa’s oncology
programs are using the body’s immune system to take multiple approaches in
fighting cancer—developing treatments and vaccines.  Anixa’s infectious disease
program consists of a treatment for COVID-19 focused on inhibiting certain
protein function necessary for viral replication.



THERAPEUTICS

CAR-T

We are developing chimeric antigen receptor T-cell (CAR-T) based immuno-therapy
drugs which genetically engineer a patient’s own immune cells to fight cancer.

COVID-19

We are developing a treatment for COVID-19 that is designed to inhibit protein
function necessary for replication of SARS-CoV-2, the virus causing the disease.


VACCINES

Breast Cancer Vaccine

We are developing a revolutionary vaccine technology focused on preventing
breast cancer, specifically triple negative breast cancer, the most lethal form
of the disease.

Ovarian Cancer Vaccine

Using a similar mechanism of action as our breast cancer vaccine technology, we
are developing a vaccine to prevent the occurrence of ovarian cancer.


SIGN UP FOR EMAIL UPDATES

Be The First to Receive Breaking News

Sign Up Now

LATEST NEWS & EVENTS

Sep 12, 2022

Anixa Biosciences' Ovarian Cancer CAR-T Therapy to be Presented at the Rivkin
Center & American Association of Cancer Research (AACR) 14th Biennial Ovarian
Cancer Research Symposium

Read More...
Aug 31, 2022

Anixa Biosciences to Present at the H.C. Wainwright 24th Annual Global
Investment Conference

Read More...
Aug 15, 2022

Anixa Biosciences Announces Treatment of First Patient in its Ovarian Cancer
CAR-T Clinical Trial

Read More...


STOCK DATA

Oct 07, 2022 • 4:00 PM EDT View Investors Relations
Nasdaq: ANIX
Price $4.75
Change 0.16
Copyrights © 2022 Anixa Biosciences, Inc.. All Rights Reserved.
Privacy Policy Disclaimer Sitemap